The MarketWatch News Department was not involved in the creation of this content. New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker ...
Real Simple on MSN
I went on a longevity retreat and I'll never think of aging the same way—here's what I learned
The lessons on longevity and making human connections immediately made sense. Thanks to these women, I felt a sense of belonging that put my mind at ease. I felt seen, but not judged. I felt like I ...
Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics market HYFT®-driven discovery supports ...
First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or ...
It was after my sonic soul journey and before my infrared-light therapy session in a giant vibrating clamshell that my longevity consultant told me I could stand to drop 20 pounds of fat. I was ...
SCOTTSDALE, Ariz., Aug. 12, 2025 /PRNewswire/ -- Jocasta Neuroscience, Inc., a preclinical stage, longevity-focused company, with its lead asset, a proprietary ...
The women's telehealth company Midi said Tuesday it's launching a longevity care program that will be covered by private insurers nationwide. Why it matters: Longevity care is booming, but it mostly ...
First publicly listed company to actively investigate psilocybin’s potential impact on longevity Working closely with an academic neuroscience faculty, Psyence BioMed is developing an accelerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback